Metastatic carcinoma of unknown primary with complete metabolic response following sorafenib-based chemotherapy

BACKGROUND: The treatment of carcinoma of unknown primary based on histopathology and immunohistochemistry is generally chemotherapy. The use of molecular markers, genetic profiling platforms, and personalized medicine is under active investigation. CASE REPORT: We report the case of a 56-year-old p...

Descripción completa

Detalles Bibliográficos
Autores principales: Usón Junior, Pedro Luiz Serrano, Wagner, Jairo, Corpa, Marcus Vinicius de Nigro, Coelho, Iracema Moraes, Nagourney, Robert A, Yamaguchi, Nise Hitomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429643/
https://www.ncbi.nlm.nih.gov/pubmed/30915220
http://dx.doi.org/10.1177/2050313X19838739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429643/
https://www.ncbi.nlm.nih.gov/pubmed/30915220
http://dx.doi.org/10.1177/2050313X19838739

Ejemplares similares